Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,827 across all filing types
Latest filing 2016-03-22 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
2015年年度股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2015 Annual General Meeting (AGM) of 哈药集团股份有限公司 (Harbin Pharmaceutical Group Co., Ltd.). It details the procedures of the AGM, including the convening, attendance, voting procedures, and the results of the shareholder votes on various agenda items such as the 2015 annual report, board and supervisory reports, financial statements, profit distribution, and auditor appointment. The document does not contain the actual annual report or financial statements but rather confirms the legality and validity of the AGM process and voting results. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA) because it officially reports the voting outcomes of the AGM. The document length is about 5442 characters, which is consistent with a detailed voting results announcement rather than the full annual report or other filings.
2016-03-22 Chinese
2015年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2015 Annual General Meeting Resolution Announcement" and details the resolutions passed at the 2015 Annual General Meeting (AGM) held on March 22, 2016. It includes voting results on various agenda items such as the 2015 annual report, board and supervisory reports, financial budget, profit distribution, auditor appointment, and credit application. The document also confirms the legality and validity of the meeting and voting procedures, with lawyer verification. The content is focused on the announcement of the voting results and resolutions from the AGM rather than the full annual report or other detailed financial disclosures. The document length is 3208 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the document fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2016-03-22 Chinese
七届十三次董事会决议公告
Capital/Financing Update Classification · 95% confidence The document is a board resolution announcement from Harbin Pharmaceutical Group Co., Ltd. regarding the approval of a proposal to apply for merger and acquisition credit facilities from banks. It details the credit amounts, banks involved, and the purpose of the credit (to support M&A activities). The document is a formal announcement of a board decision and does not contain financial statements, earnings data, or detailed financial analysis. It is not a full report like an Annual Report or Interim Report, nor is it a call transcript or audit report. The content focuses on financing related to M&A activities, specifically the approval of credit lines for M&A purposes. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is short (1208 characters), but it contains substantive information about financing decisions rather than just announcing a report publication or regulatory filing. Hence, it is not RPA or RNS.
2016-03-21 Chinese
关于银杏叶产品自查情况的进展公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 哈药集团股份有限公司 regarding the progress of a self-inspection related to ginkgo leaf products. It details regulatory actions, administrative penalties, and company responses to quality issues with supplied raw materials. The text is relatively short (1271 characters) and focuses on regulatory compliance and public disclosure of an ongoing issue rather than presenting financial data, management changes, or detailed financial reports. It does not contain financial statements or earnings data, nor is it a report of voting results or a call transcript. The content fits best as a Regulatory Filing (RNS) because it is a regulatory announcement about compliance and penalties without fitting into more specific categories like Audit Report or Legal Proceedings Report (which would require more detailed legal case information).
2016-03-15 Chinese
2015年年度股东大会会议材料
AGM Information Classification · 100% confidence The document is titled as materials for the 2015 Annual General Meeting (AGM) of 哈药集团股份有限公司, dated March 22, 2016. It includes detailed agenda items such as the 2015 annual report full text and summary, board work report, supervisory board work report, financial statements and budget proposals, profit distribution and capital increase plans, audit work summary and reappointment of the accounting firm, bank credit application, and independent directors' reports. The content is comprehensive and clearly intended as meeting materials for the AGM, including reports and proposals to be discussed and voted on at the meeting. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting. The document is lengthy (15,000 characters) and contains detailed meeting agenda and reports, not just an announcement or a brief summary. Therefore, the correct classification is AGM Information (AGM-R).
2016-03-11 Chinese
关于召开2015年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2015 Annual General Meeting (AGM) of 哈药集团股份有限公司, including details such as the date, voting methods, agenda items, and instructions for shareholders. It does not contain the actual annual report or financial statements but rather information about the meeting where such reports will be discussed and voted on. The document length is 3236 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, it fits the category of AGM Information (AGM-R).
2016-03-01 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.